期刊： BRITISH JOURNAL OF PSYCHIATRY, 2023; 222 (3)
Comparing the recommendations of two recently published national clinical practice guidelines for depression, this editorial highlights the concordanc......
期刊： BRITISH JOURNAL OF PSYCHIATRY, 2023; 223 (1)
Negative symptoms are an important symptom dimension in schizophrenia that are often least responsive to antipsychotic medications. We revisit the cur......
期刊： BRITISH JOURNAL OF PSYCHIATRY, 2023; 223 (5)
In this editorial we, as members of the 2022 NICE Guideline Committee, highlight and discuss what, in our view, are the key guideline recommendations ......
期刊： BRITISH JOURNAL OF PSYCHIATRY, 2023; 222 (1)
Background Evidence on the role of co-occurring psychiatric disorders in mortality associated with psychotic depression is limited. Aims To estimate t......
期刊： BRITISH JOURNAL OF PSYCHIATRY, 2023; 222 (6)
BackgroundAlthough clozapine is the most efficacious medication for treatment-refractory schizophrenia, not all patients will have an adequate respons......
期刊： BRITISH JOURNAL OF PSYCHIATRY, 2023; 223 (2)
BackgroundThe antipsychotic aripiprazole is often used in the treatment of first-episode psychosis. Measuring aripiprazole blood levels provides an ob......
